Bamco Inc. NY raised its position in shares of Heartflow, Inc. (NASDAQ:HTFL – Free Report) by 86.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,303,877 shares of the company’s stock after purchasing an additional 1,066,371 shares during the quarter. Bamco Inc. NY owned approximately 2.71% of Heartflow worth $67,158,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Boothbay Fund Management LLC acquired a new stake in Heartflow during the 4th quarter valued at approximately $330,000. Freestone Grove Partners LP increased its position in Heartflow by 400.0% during the 4th quarter. Freestone Grove Partners LP now owns 150,000 shares of the company’s stock valued at $4,372,000 after purchasing an additional 120,000 shares during the period. Sandia Investment Management LP increased its position in Heartflow by 112.2% during the 4th quarter. Sandia Investment Management LP now owns 15,917 shares of the company’s stock valued at $464,000 after purchasing an additional 8,417 shares during the period. Rock Springs Capital Management LP increased its position in Heartflow by 11.1% during the 4th quarter. Rock Springs Capital Management LP now owns 277,700 shares of the company’s stock valued at $8,095,000 after purchasing an additional 27,700 shares during the period. Finally, Capricorn Investment Group LLC acquired a new stake in Heartflow during the 4th quarter valued at approximately $48,178,000.
Analysts Set New Price Targets
Several brokerages have recently commented on HTFL. Wells Fargo & Company raised their price objective on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, June 12th. JPMorgan Chase & Co. reduced their price target on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research report on Thursday, March 19th. Piper Sandler reissued an “overweight” rating on shares of Heartflow in a research report on Thursday, June 11th. Finally, William Blair began coverage on shares of Heartflow in a research report on Monday, May 4th. They issued an “outperform” rating for the company. Six research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $37.00.
Insider Transactions at Heartflow
In other news, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction on Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the sale, the insider directly owned 78,731 shares in the company, valued at $2,231,236.54. The trade was a 10.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 22,562 shares of Heartflow stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $28.50, for a total value of $643,017.00. Following the sale, the chief executive officer owned 496,835 shares in the company, valued at $14,159,797.50. The trade was a 4.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,141,438 shares of company stock worth $62,651,098 in the last ninety days. Company insiders own 7.70% of the company’s stock.
Heartflow Price Performance
HTFL opened at $32.84 on Thursday. The company has a market capitalization of $2.83 billion and a price-to-earnings ratio of -10.56. The firm’s fifty day moving average price is $29.74 and its two-hundred day moving average price is $28.34. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $41.22.
Heartflow (NASDAQ:HTFL – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.08. The firm had revenue of $52.59 million for the quarter. The company’s quarterly revenue was up 41.3% compared to the same quarter last year. As a group, equities analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current year.
Heartflow Profile
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
Featured Stories
- Five stocks we like better than Heartflow
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
